RP

Royalty Pharma PLCNASDAQ RPRX Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

12.655

Large

Exchange

XNAS - Nasdaq

View Section: Financials

Royalty Pharma Statements

RP

Royalty Pharma Income Statement

B

M

USD (except Earnings per share)

Financial

Revenue

Cost of sales

Gross profit

Research and development

Selling, general and administrative

Total operating expenses

Operating income

Interest expense

Other income

Income before tax

Provision for income taxes

Net income

Diluted earnings per share

Shares outstanding after dilution

2024-06-30
%

537.27

100

0

0

0.5

0.09

54.708

10.2

267.64

49.8

269.63

50.2

-81.253

-15.1

6

1.1

194.38

36.2

0

102

19

0.17

596.91

2024-03-31
%

567.98

100

0

0

0.5

0.09

57.652

10.2

641.75

113

-73.774

-13

73.186

12.9

-3.685

-0.6

-4.273

-0.8

0

4.778

0.8

0.011

597.48

2023-12-31
%

596.07

100

0

0

0.5

0.08

59.185

9.9

-16.828

-2.8

612.9

102.8

123

20.6

-18.308

-3.07

717.59

120.4

0

494.34

82.9

0.82

597.45

2023-09-30
%

536.3

100

0

0

50.5

9.4

57.2

10.7

384.9

71.8

151.4

28.2

-27.7

-5.2

-1.7

-0.3

122.1

22.8

0

72.1

13.4

0.11

601.1

2023-06-30
%

538.2

100

0

0

0.5

0.09

47.6

8.8

289.4

53.8

248.8

46.2

101.4

18.8

1.1

0.2

351.3

65.3

0

227.6

42.3

0.37

605.9

2023-03-31
%

684

100

0

0

0.5

0.07

85.7

12.5

205

30

479

70

32.9

4.8

-2.8

-0.4

509.1

74.4

0

340.8

49.8

0.56

607.3

2022-12-31
%

565.7

100

0

0

50.5

8.9

73.2

12.9

432.6

76.5

133.1

23.5

-126.2

-22.3

-1.2

-0.2

-610

-107.8

0

-456.1

-80.6

-1.03

442.2

2022-09-30
%

573.5

100

0

0

25.5

4.4

50.7

8.8

381.3

66.5

192.2

33.5

39

6.8

-10.8

-1.9

220.4

38.4

0

142.7

24.9

0.23

607.2

2022-06-30
%

536

100

0

0

0.6

0.1

51.8

9.7

158.2

29.5

377.8

70.5

114.8

21.4

-1

-0.2

491.6

91.7

0

304.5

56.8

0.5

607.2

2022-03-31
%

562

100

0

0

100.5

17.9

51.5

9.2

342.3

60.9

219.7

39.1

-89.9

-16

-1.8

-0.3

128.1

22.8

0

51.8

9.2

0.08

607.2

2021-12-31
%

575.7

100

0

0

103.8

18

46.2

8

422.3

73.4

153.4

26.6

-94.9

-16.5

-4.8

-0.8

53.7

9.3

0

7.9

1.4

0.02

431.4

2021-09-30
%

585.8

100

0

0

90.5

15.4

48.6

8.3

282.7

48.3

303.1

51.7

-80.5

-13.7

-0.8

-0.1

221.8

37.9

0

101.9

17.4

0.16

607.2

2021-06-30
%

555

100

0

0

3.1

0.6

44.9

8.1

-190

-34.2

744.9

134.2

61.9

11.2

-0.1

-0.02

806.8

145.4

0

440.8

79.4

0.72

607.2

2021-03-31
%

573

100

0

0

2.6

0.5

43.2

7.5

343.7

60

229.3

40

-70.4

-12.3

0

159

27.7

0

69.1

12.1

0.11

607.1

2020-12-31
%

572.1

100

0

0

7.8

1.4

50.1

8.8

193

33.7

379.2

66.3

56.4

9.9

1.6

0.3

366.6

64.1

0

171.1

29.9

0.43

398.6

2020-09-30
%

538.4

100

0

0

5.1

0.9

50.7

9.4

27.8

5.2

510.6

94.8

137

25.4

1.8

0.3

624.3

116

0

290.6

54

0.79

370

2020-06-30
%

510.9

100

0

0

5.8

1.1

42.8

8.4

101.6

19.9

409.3

80.1

192.4

37.7

0.3

0.06

602

117.8

0

33.5

6.6

0.09

354

2020-03-31
%

500.9

100

0

0

7.6

1.5

38.1

7.6

139.4

27.8

361.4

72.2

-246.4

-49.2

-5.9

-1.2

109.1

21.8

0

0

595.4

2019-06-30
%

457.6

100

0

0

21.5

4.7

30.3

6.6

129.7

28.3

327.9

71.7

-149.1

-32.6

0

178.8

39.1

0

151.7

33.2

0.25

595.4

2019-03-31
%

434.9

100

0

0

23

5.3

24.4

5.6

4

0.9

430.9

99.1

-34.9

-8.02

0.1

0.02

396.1

91.1

0

367.4

84.5

0.62

595.4

View Section: Balance Sheet